Reansa Medical Services Limited - Accounts to registrar (filleted) - small 23.2.5

REGISTERED NUMBER: 04576123 (England and Wales)

REANSA MEDICAL SERVICES LIMITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31ST OCTOBER 2023

Page

Balance Sheet

1

FIXED ASSETS

3

3

CURRENT ASSETS

83,963

67,810

CREDITORS

Amounts falling due within one year

(50,227

)

(36,231

)

NET CURRENT ASSETS

33,736

31,579

TOTAL ASSETS LESS CURRENT LIABILITIES

33,739

31,582

CAPITAL AND RESERVES

33,739

31,582

NOTES TO THE FINANCIAL STATEMENTS

1.	STATUTORY INFORMATION

Reansa Medical Services Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

04576123

Registered office:

1st Floor Tudor House

16 Cathedral Road

Cardiff

CF11 9LJ

2.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was NIL (2022 - NIL).

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st October 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st October 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 19th January 2024 and were signed by:

Dr I J Williamson - Director